Ranitidine sold as Rantac, Zinetac removed from Essential Medicines’ List over cancer concerns

New Delhi: The Ministry of Health has removed antacid salt Ranitidine, popularly sold as Rantac Zantac, from the National List of Essential Medicines 2022 over cancer concerns.

Ranitidine is among 26 medicines dropped from the NLEM 2015 version.

Due to numerous reviews of capacity cancer-inflicting issues, the salt in ranitidine has come under scrutiny globally.

In India, doctors frequently prescribe ranitidine to deal with signs inclusive of coughing up acid, indigestion, belly pain, and heartburn.

In 1988, Zantac have become one of the first medicinal drugs withinside the international to sell $1 billion really well worth of medication annually. 

Due to alleged carcinogen contamination, American Food and Drug Administration (USFDA) eliminated of all prescription and over-the-counter (OTC) Ranitidine medicinal drugs from the marketplace in 2020.

Similarly Gliptins will be added as it is highly used to deal with Type 2 diabetes.

In India, the marketplace for Gliptin is really well worth extra than Rs 4,000 crore, the pinnacle producer of teneligliptin, Glenmark of Mumbai, has a marketplace price of Rs 1,000 crore. The price of the Gliptin marketplace in India is round Rs 4,000 crore. 

The 26 excluded medicines include:

1. Alteplase

2. Atenolol

3. Bleaching Powder

4. Capreomycin

5. Cetrimide

6. Chlorpheniramine

7. Diloxanide furoate

8. Dimercaprol

9. Erythromycin

10. Ethinylestradiol

11. Ethinylestradiol(A) Norethisterone (B)

12. Ganciclovir

13. Kanamycin

14. Lamivudine (A) + Nevirapine (B) + Stavudine (C)

15. Leflunomide

16. Methyldopa

17. Nicotinamide

18. Pegylated interferon alfa 2a, Pegylated interferon alfa 2b

19. Pentamidine

20. Prilocaine (A) + Lignocaine (B)

21. Procarbazine

22. Ranitidine

23. Rifabutin

24. Stavudine (A) + Lamivudine (B) 25. Sucralfate

26. White Petrolatum

Published on: Tuesday, September 13, 2022, 06:49 PM IST